JPMorgan Chase & Co’s Regulus Therapeutics RGLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-74,517
| Closed | -$130K | – | 6531 |
|
|
2025
Q1 | $130K | Sell |
74,517
-115,940
| -61% | -$203K | ﹤0.01% | 4619 |
|
|
2024
Q4 | $301K | Buy |
190,457
+111,485
| +141% | +$176K | ﹤0.01% | 4371 |
|
|
2024
Q3 | $124K | Buy |
78,972
+52,059
| +193% | +$81.7K | ﹤0.01% | 4644 |
|
|
2024
Q2 | $48K | Buy |
26,913
+7,171
| +36% | +$12.8K | ﹤0.01% | 4917 |
|
|
2024
Q1 | $56.9K | Buy |
19,742
+19,713
| +67,976% | +$56.8K | ﹤0.01% | 4926 |
|
|
2023
Q4 | $37 | Buy |
29
+9
| +45% | +$11 | ﹤0.01% | 6209 |
|
|
2023
Q3 | $28 | Buy |
+20
| New | +$28 | ﹤0.01% | 6142 |
|
|
2019
Q4 | – | Sell |
-7
| Closed | – | – | 4852 |
|
|
2019
Q3 | $0 | Hold |
7
| – | – | ﹤0.01% | 4884 |
|
|
2019
Q2 | $0 | Buy |
+7
| New | – | ﹤0.01% | 4918 |
|
|
2018
Q4 | – | Sell |
-7
| Closed | – | – | 4956 |
|
|
2018
Q3 | $0 | Hold |
7
| – | – | ﹤0.01% | 4863 |
|
|
2018
Q2 | $1K | Buy |
+7
| New | +$1K | ﹤0.01% | 4719 |
|
|
2017
Q4 | – | Sell |
-63
| Closed | -$10K | – | 4718 |
|
|
2017
Q3 | $10K | Sell |
63
-77
| -55% | -$12.2K | ﹤0.01% | 4053 |
|
|
2017
Q2 | $17K | Buy |
+140
| New | +$17K | ﹤0.01% | 3957 |
|